Taichi Miyawaki, Takehito Shukuya, Kentaro Sakamaki, Toshiaki Takahashi, Suguru Matsuda, Kentaro Tanaka, Hiroaki Akamatsu, Yuki Sato, Takayuki Takahama, Tomoiki Aiba, Takeshi Masuda, Naoki Furuya, Toshihide Yokoyama, Motoko Tachihara, Isamu Okamoto, Hirotsugu Kenmotsu, Nobuyuki Yamamoto. "Randomized phase II study of amivantamab + lazertinib versus afatinib in patients with uncommon/compound
                    <i>EGFR</i>
                    -mutated non-small cell lung cancer (WJOG17323L: AGEHA study).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps8676